Know what's inside:
 GBA Group bundles broader range of offerings in new Life Sciences division

GBA Group bundles broader range of offerings in new Life Sciences division

Hamburg, January 17, 2022 - In recent months, GBA Group has significantly expanded its service portfolio for customers in the pharmaceutical, medical device, cosmetics and agrochemical industries. Against this backdrop, the activities in this area will be combined in the new Life Sciences division in order to use the know-how available in these areas in the GBA network even more efficiently for customers in the future. The international network of companies, scientists, experienced project managers and highly qualified laboratory experts is thus even better able to offer expert support across locations and disciplines in a variety of areas of the research, development and product life cycle.

GBA Group thus underlines its commitment to making a significant contribution to maintaining and improving health as the basis for a better quality of life through its three divisions Life Sciences, Food and Environment and the expertise from research, development and quality assurance bundled there.

Steffen Walter, CEO GBA Group, has a clear goal in mind: "Global efforts in the field of health protection will continue to grow in the future. Against this backdrop, GBA Group has significantly expanded its Life Sciences portfolio and will continue to invest in this growth market in order to position itself as a professionally broad and internationally situated laboratory service provider as well as a provider of other services for the benefit of our society."

For a detailed description of our services, please check the described services on our website and contact the specified contact persons.

Please direct any queries to:
Sabine Nest

© 2023 GBA Group

Follow Us

  • linkedIn GBA Pharma
  • xing
  • GBA youtube
  • gba Instagram
ContactData PrivacyLegal NoticeTerms & ConditionsDisclosure
Phone Phone